
Janet B McGill MD MA, FACE, FACP
Diabetes, Lipid Metabolism, Thyroid
Professor of Medicine, Washington University St Louis
Join to view full profile
4921 Parkview Pl# DvSt. Louis, MO 63110
Phone+1 314-362-3500
Fax+1 314-230-1119
Dr. McGill is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Endocrinology, Diabetes, and Metabolism, 1985 - 1987
Beaumont Hospital, Royal OakFellowship, Endocrinology, Diabetes, and Metabolism, 1984 - 1985
Corewell Health East Beaumont (Royal Oak)Residency, Internal Medicine, 1980 - 1984
Michigan State University College of Human MedicineClass of 1979
Certifications & Licensure
MO State Medical License 1985 - 2027
MI State Medical License 1981 - 2003
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Outstanding Physician Clinician in Diabetes American Diabetes Association, 2022
- America's Top Doctors Castle Connolly, 2007-2022
- Excellence in Teaching Washington University, 2020
Clinical Trials
Publications & Presentations
PubMed
- Impact of Simultaneous Initiation of Finerenone and Empagliflozin on Albuminuria Irrespective of Baseline HbA1c Levels: A Participant-Level Exploratory Analysis of the...Janet B McGill, Jennifer B Green, Hiddo J L Heerspink, Johannes F E Mann, Amy K Mottl
Diabetes, Obesity & Metabolism. 2026-09-01 - Safety and Synergy of Finerenone and Empagliflozin in Lowering Blood Pressure.Rajiv Agarwal, Ricardo Correa-Rotter, Sankar D Navaneethan, Hiddo J L Heerspink, Matthew R Weir
Hypertension. 2026-09-01 - Effect of Finerenone on Albuminuria in Type 1 Diabetes by Baseline HbA1c Level and Diabetes Duration: An Exploratory Analysis of the FINE-ONE Trial.Jelle M Beernink, Hiddo J L Heerspink, Andreas L Birkenfeld, David Z I Cherney, Helen M Colhoun
Diabetes Care. 2026-08-01
Journal Articles
- Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults with Type 1 DiabetesAnuj Bhargava, Robin Goland, Irl B Hirsch, Yogish C Kudva, Janet B Mcgill, Louis Philipson, Francesco Vendrame, Ruth S Weinstock, JAMA
- Late-Onset T1DM and Older Age Predict Risk of Additional Autoimmune DiseaseKavita Juneja, Janet B McGill, Jing W Hughes, Garry S Tobin, C Rachel Kilpatrick, Diabetes Care
Lectures
- New Strategies for Obesity Management: Risk Stratification & Long-term Weight ControlAmerican Association of Clinical Endocrinologists (AACE), Novi, Michigan - 10/11/2013
- New Strategies for Obesity Management: Risk Stratification & Long-term Weight ControlAmerican Association of Clinical Endocrinologists (AACE), Novi, Michigan - 10/11/2013
- Hot Topics in Internal Medicine - CME Getaways Las VegasCME Getaways, Las Vegas, Nevada - 9/28/2012
Authored Content
- Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults with Type 1 DiabetesJune 2020
Press Mentions
KERENDIA (Finerenone) Meets Primary Endpoint in Phase III Clinical Trial for Adults with Type 1 Diabetes and Chronic Kidney DiseaseNovember 6th, 2025
McGill to Receive Award from Diabetes OrganizationApril 18th, 2022
Finerenone plus SGLT2 Inhibition May Yield Additive CV, Kidney Benefits: FIGARO-DKDOctober 5th, 2021
Grant Support
- Diabetes Research And Training CenterNational Institute Of Diabetes And Digestive And Kidney Diseases2007
- The Dream StudyNational Center For Research Resources2004–2007
- Bypass Angioplasty Revascularization Investigation 2 Diabetes (Bari 2d)National Center For Research Resources2005
- Early Diabetes Intervention Program (EDIP)National Center For Research Resources1999–2005
- Early Diabetes Intervention Program. (EDIP)National Center For Research Resources2004
Committees
- member, AACE/ACE Comprehensive Type 2 Diabetes Management Algorithm 2033
- member, AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN 2015
- member, AACE/ACE COMPREHENSIVE DIABETES MANAGEMENT ALGORITHM 2015
- member, 2011 AACE Medical Guidelines for Clinical Practice for Developing a Diabetes Mellitus Comprehensive Care Plan
- member, CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM 2016 EXECUTIVE SUMMARY
Professional Memberships
- Member
- Endocrine SocietyMember
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









